Trials / Unknown
UnknownNCT04500392
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity: a Randomized Multicenter Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Hypoxia is the most common adverse event during gastrointestinal endoscopes sedated with propofol and sufentanil, especially in obese people. In the present study, high-flow nasal cannula oxygenation will be utilized in order to reduce the incidence of hypoxia among obesity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | High-flow nasal cannula oxygenation | Oxygen is supplied with a high-flow nasal cannula oxygenation device#the flow is up to 60L/min |
| DEVICE | Regular nasal cannula | Oxygen is supplied with a regular nasal cannula #the flow is up to 6L/min |
Timeline
- Start date
- 2021-05-06
- Primary completion
- 2024-01-01
- Completion
- 2024-01-01
- First posted
- 2020-08-05
- Last updated
- 2024-01-11
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04500392. Inclusion in this directory is not an endorsement.